Invesco Ltd. Increases Holdings in Select Medical Holdings Co. (NYSE:SEM)

Invesco Ltd. lifted its position in shares of Select Medical Holdings Co. (NYSE:SEM) by 77.1% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,281,674 shares of the health services provider’s stock after buying an additional 557,860 shares during the period. Invesco Ltd. owned about 0.96% of Select Medical worth $19,225,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Advisors Asset Management Inc. raised its holdings in shares of Select Medical by 94.2% during the 4th quarter. Advisors Asset Management Inc. now owns 1,785 shares of the health services provider’s stock valued at $42,000 after buying an additional 866 shares in the last quarter. Sofos Investments Inc. grew its position in Select Medical by 1,053.6% during the 4th quarter. Sofos Investments Inc. now owns 1,292 shares of the health services provider’s stock worth $51,000 after acquiring an additional 1,180 shares during the last quarter. Tower Research Capital LLC TRC bought a new position in Select Medical during the 4th quarter worth approximately $55,000. Advisor Group Inc. grew its position in Select Medical by 85.0% during the 4th quarter. Advisor Group Inc. now owns 2,479 shares of the health services provider’s stock worth $57,000 after acquiring an additional 1,139 shares during the last quarter. Finally, Mutual of America Capital Management LLC grew its position in Select Medical by 23.7% during the 1st quarter. Mutual of America Capital Management LLC now owns 4,745 shares of the health services provider’s stock worth $71,000 after acquiring an additional 909 shares during the last quarter. 76.07% of the stock is currently owned by institutional investors.

SEM has been the topic of several recent research reports. ValuEngine upgraded Select Medical from a “sell” rating to a “hold” rating in a research report on Wednesday, April 29th. Benchmark reduced their price target on Select Medical from $33.00 to $25.00 and set a “buy” rating on the stock in a research report on Tuesday, March 24th. TheStreet lowered Select Medical from a “b-” rating to a “c+” rating in a research report on Wednesday, April 22nd. Wells Fargo & Co reduced their price target on Select Medical from $31.00 to $24.00 and set an “overweight” rating on the stock in a research report on Monday, May 4th. Finally, Deutsche Bank cut their price objective on Select Medical from $33.00 to $24.00 and set a “buy” rating on the stock in a research report on Friday, April 24th. One analyst has rated the stock with a sell rating, two have given a hold rating and four have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of $22.00.

In other news, EVP Martin F. Jackson sold 49,745 shares of the firm’s stock in a transaction that occurred on Wednesday, June 3rd. The stock was sold at an average price of $17.08, for a total value of $849,644.60. Following the completion of the transaction, the executive vice president now owns 1,601,953 shares in the company, valued at approximately $27,361,357.24. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 19.70% of the company’s stock.

Shares of SEM stock opened at $14.35 on Wednesday. The firm has a market cap of $1.82 billion, a P/E ratio of 11.96, a P/E/G ratio of 1.03 and a beta of 1.44. Select Medical Holdings Co. has a fifty-two week low of $10.00 and a fifty-two week high of $28.61. The business’s 50 day moving average price is $15.53 and its 200-day moving average price is $19.25. The company has a debt-to-equity ratio of 4.53, a quick ratio of 1.18 and a current ratio of 1.18.

Select Medical (NYSE:SEM) last issued its quarterly earnings data on Thursday, April 30th. The health services provider reported $0.37 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.32 by $0.05. The firm had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.36 billion. Select Medical had a return on equity of 18.74% and a net margin of 2.90%. The business’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same period last year, the company earned $0.27 EPS. As a group, equities analysts predict that Select Medical Holdings Co. will post 0.88 EPS for the current year.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiary, Select Medical Corporation, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates through four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.

Read More: What is a Buy-Side Analyst?

Institutional Ownership by Quarter for Select Medical (NYSE:SEM)

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.